NCT00335660View on ClinicalTrials.gov

Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity

PHASE2TerminatedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

September 30, 2007

Conditions
Overactive Bladder Syndrome
Interventions
DRUG

AV608

Trial Locations (13)

Unknown

Amsterdam

Nieuwegein

Zeist

Birmingham

Blackburn

Chertsey

Hull

Leeds

Liverpool

London

Plymouth

Sheffield

Falkirk

Sponsors
All Listed Sponsors
lead

Avera Pharmaceuticals

INDUSTRY

NCT00335660 - Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity | Biotech Hunter | Biotech Hunter